Literature DB >> 25596283

SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis.

Lin Yu1, Xin Liu1, Kang Cui1, Yanbo Di1, Lingbiao Xin1, Xiaoming Sun1, Wei Zhang1, Xi Yang2, Minxin Wei3, Zhi Yao4, Jie Yang5.   

Abstract

SND1 is an AEG-1/MTDH/LYRIC-binding protein that is upregulated in numerous human cancers, where it has been assigned multiple functional roles. In this study, we report its association with the TGFβ1 signaling pathway, which promotes epithelial-mesenchymal transition (EMT) in breast cancer. SND1 was upregulated in breast cancer tissues, in particular in primary invasive ductal carcinomas. Transcriptional activation of the SND1 gene was controlled by the TGFβ1/Smad pathway, specifically by activation of the Smad2/Smad3 complex. The SND1 promoter region contained several Smad-specific recognition domains (RD motifs), which were recognized and bound by the Smad complex that enhanced the transcriptional activation of SND1. We found that SND1 promoted expression of the E3 ubiquitin ligase Smurf1, leading to RhoA ubiquitination and degradation. RhoA degradation in breast cancer cells disrupted F-actin cytoskeletal organization, reduced cell adhesion, increased cell migration and invasion, and promoted metastasis. Overall, our results define a novel role for SND1 in regulating breast tumorigenesis and metastasis. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25596283     DOI: 10.1158/0008-5472.CAN-14-2387

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.

Authors:  L Yu; Y Di; L Xin; Y Ren; X Liu; X Sun; W Zhang; Z Yao; J Yang
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 2.  Regulating Rho GTPases and their regulators.

Authors:  Richard G Hodge; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-06-15       Impact factor: 94.444

3.  miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1.

Authors:  Junrong Wang; Yubo Hu; Cong Ye; Junbao Liu
Journal:  Hum Cell       Date:  2020-05-14       Impact factor: 4.174

4.  The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.

Authors:  Lin Yu; Jinling Xu; Jing Liu; Huibian Zhang; Cuiyun Sun; Qian Wang; Cuijuan Shi; Xuexia Zhou; Dan Hua; Wenjun Luo; Xiuwu Bian; Shizhu Yu
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

5.  SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.

Authors:  Xiaoteng Cui; Chunyan Zhao; Xuyang Yao; Baoxin Qian; Chao Su; Yuanyuan Ren; Zhi Yao; Xingjie Gao; Jie Yang
Journal:  RNA Biol       Date:  2018-10-25       Impact factor: 4.652

6.  Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Jarrod W Barnes; Elif T Kucera; Liping Tian; Noël E Mellor; Nina Dvorina; William W Baldwin; Micheala A Aldred; Carol F Farver; Suzy A A Comhair; Metin Aytekin; Raed A Dweik
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

7.  Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).

Authors:  Devaraja Rajasekaran; Nidhi Jariwala; Rachel G Mendoza; Chadia L Robertson; Maaged A Akiel; Mikhail Dozmorov; Paul B Fisher; Devanand Sarkar
Journal:  J Biol Chem       Date:  2016-03-20       Impact factor: 5.157

Review 8.  Tudor staphylococcal nuclease: biochemistry and functions.

Authors:  Emilio Gutierrez-Beltran; Tatiana V Denisenko; Boris Zhivotovsky; Peter V Bozhkov
Journal:  Cell Death Differ       Date:  2016-09-09       Impact factor: 15.828

9.  Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress.

Authors:  Xiao Fu; Chunyan Zhang; Hao Meng; Kai Zhang; Lei Shi; Cheng Cao; Ye Wang; Chao Su; Lingbiao Xin; Yuanyuan Ren; Wei Zhang; Xiaoming Sun; Lin Ge; Olli Silvennoinen; Zhi Yao; Xi Yang; Jie Yang
Journal:  Cell Death Differ       Date:  2018-02-19       Impact factor: 15.828

10.  Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Authors:  Li Wang; JianTao Wang; Zhixi Li; YanYang Liu; Ming Jiang; Yan Li; Dan Cao; Maoyuan Zhao; Feng Wang; Feng Luo
Journal:  Tumour Biol       Date:  2015-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.